UBE2Q2 pseudogene 16 (UBE2Q2P16)

UBE2Q2 pseudogene 16 (UBE2Q2P16) is a non-coding genomic sequence classified as a pseudogene, meaning it shares homology with the functional gene Ubiquitin-conjugating enzyme E2 Q2 (UBE2Q2), but does not produce a functional protein[3][4][5]. Pseudogenes are typically transcriptionally inactive and are not considered druggable or therapeutic targets. There are no known biological functions, mechanisms, disease causality roles, or pharmacological interactions directly attributable to UBE2Q2P16. Some database listings may show disease associations (e.g., spinal muscular atrophy, trilateral retinoblastoma), but these are general to the genomic region, not to this pseudogene’s function[4]. Critical note: - The term "UBE2Q2 pseudogene 16" specifically refers to a pseudogene and not the functional protein or enzyme "Ubiquitin-conjugating enzyme E2 Q2" (UBE2Q2), which is a real enzyme involved in protein ubiquitination[2][3][4]. - If the intended target is the active enzyme, refer to "Ubiquitin-conjugating enzyme E2 Q2" (UBE2Q2) instead[2]. Summary: UBE2Q2P16 is not a protein, enzyme, receptor, or drug target; it is a pseudogene with no known biological function or therapeutic relevance[3][4][5].

Other names

UBE2Q2L (previous symbol)UBE2Q2 Pseudogene 16